Loading... Please wait...
Sort by:
  • Trends in Digital Physician Engagement
    Learn More Trends in Digital Physician Engagement
    Next level opportunities for developing physician relationships across pharma's business Digital technology has transformed pharma's communications with often difficult to engage physicians. But merely having a suite of...
  • Trends in Digital Patient Engagement
    Learn More Trends in Digital Patient Engagement
    Embedding digital patient engagement throughout the patient journey Pharma companies have made good progress with digital delivery within innovative patient support programs—but there is still significant scope to...
  • Injectables and Implantables
    Learn More Injectables and Implantables
    Injectables and implantables are key to advancing patient centricity and adherence The development of controlled and prolonged release injectable and implantable drugs has seen huge leaps forward in recent years...
  • The Digitisation of Diabetes: Opportunities and Challenges for Industry
    Learn More The Digitisation of Diabetes: Opportunities and Challenges for Industry
    Assessing the revolutionary impact of digital technologies on the management of diabetes Advanced digital technologies and devices are driving fundamental change in the management of both Type 1 and 2...
  • Biosimilars: Go-to-Market Case Studies
    Learn More Biosimilars: Go-to-Market Case Studies
    As the biosimilar sector matures, what are the key issues that are shaping commercial strategies? As physician and payer confidence in the use of biosimilars grows, US and European companies are having to rethink their...
  • Digital Technologies: New Strategies for Customer Engagement
    Learn More Digital Technologies: New Strategies for Customer Engagement
    Digital technology is transforming customer engagement Pharma has embraced the digital revolution with open arms—clearly it offers exciting new opportunities for customer engagement. But initial enthusiasm...
  • Market Access for Cell and Gene Therapies
    Learn More Market Access for Cell and Gene Therapies
    Pharma challenged to rethink its market access strategies While the promise of cell and gene therapy (C&GT) to deliver enduring or even curative treatments is welcomed there is no long-term market experience and...
  • Partnering in Digital Health: Pharma and Tech Companies
    Learn More Partnering in Digital Health: Pharma and Tech Companies
    The secret of successful digital health partnerships Digital health is guaranteed to play a huge part in the future of pharma. Innovative technology that can improve patient access, increase quality of care, boost...
  • Paying for Digital Health: Payer Insights (2019)
    Learn More Paying for Digital Health: Payer Insights (2019)
    Which digital health technologies are exciting payers? How and where can digital health technology improve patient outcomes and save payers money? Across the digital health field there are hundreds of applications...
  • Pricing and Reimbursement in Oncology
    Learn More Pricing and Reimbursement in Oncology
    Payers want pharma to address the challenges they face Specialised cancer therapies such as checkpoint inhibitors have significantly improved outcomes for patients—but for payers they represent a growing pricing...
  • Real World Evidence: The Role of Medical Affairs
    Learn More Real World Evidence: The Role of Medical Affairs
    How well has RWE integrated into Medical Affairs—and should more be done? Payers and other stakeholders increasingly expect to see real world evidence (RWE) to support their decision making. Since being added to...
  • The Role of Patient Journey Mapping in Patient Engagement
    Learn More The Role of Patient Journey Mapping in Patient Engagement
    Are you employing the latest technology and techniques to power your patient journey mapping? "Pharma companies first need to understand that their task is not to produce new product; their task is to provide a really...
  • Biomarkers and Companion diagnostics: Payer Insights
    Learn More Biomarkers and Companion diagnostics: Payer Insights
    What do you need to do to get payer support for companion diagnostics and biomarkers? The investment decisions made by the biggest players in core disease areas drive market trends—so it's crucial to understand...
  • AI in Medical Diagnostics
    Learn More AI in Medical Diagnostics
    Evaluating the potential of artificial intelligence to revolutionise and expand medical diagnostics Artificial intelligence (AI) driven technologies have already radically changed practice and outcomes in medical...
  • Health Insurance Disruptors: Going Digital
    Learn More Health Insurance Disruptors: Going Digital
    Health insurance: how to thrive in an increasingly digital health world Health insurers are being challenged to develop a portfolio of digital services with limited knowledge of their effectiveness and at a considerable...
  • Innovative drugs: Mapping the Pricing and Reimbursement Landscape (2020)
    Learn More Innovative drugs: Mapping the Pricing and Reimbursement Landscape (2020)
    Drug innovation is delivering highly-effective medicines that significantly improve patient outcomes and, in some cases, are curative of disease. Yet of the 55 medicines that were approved in the US between January 2018...
  • Interoperability in Health
    Learn More Interoperability in Health
    Experts agree interoperability will unlock considerable value across healthcare Interoperability—enabling information systems to share data—offers a wealth of opportunities for multiple health stakeholders,...
  • Pricing Transparency in Pharma
    Learn More Pricing Transparency in Pharma
    Pharma challenged to engage and shape the drug pricing transparency debate Anxieties about rising drug prices is fuelling an ever louder global demand for price transparency—and reformers are getting their message...
  • Regulating Digital Health
    Learn More Regulating Digital Health
    As digital health progressively enters mainstream therapy, how should it be regulated and to what outcome? Digital health is booming and as investment in digital health technology grows more products and services will...
  • The Future of Disease Interception
    Learn More The Future of Disease Interception
    What does pharma need to do to develop this radical health model of the future? Disease interception is a novel healthcare model that identifies, treats and sometimes cures disease before it is fully manifested. There...

customer.service@firstwordpharma.com

All Contents Copyright © 2020 Doctor's Guide Publishing Limited All Rights Reserved